Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ProtoKinetix Inc PKTX

Healthcare Biotechnology
ProtoKinetix, Incorporated is a research and development stage biotechnology company. The Company is focused on scientific medical research of Anti-Freeze Glycoproteins (AFGPs) or anti-aging glycoproteins. The Company’s anti-aging glycopeptide is for ophthalmology, dermatology, transplant support and biomanufacturing. The commercial applications for AAGPs include various health care solutions... see more

Recent & Breaking News (OTCQB:PKTX)

ProtoKinetix Upgrades to OTCQB

PR Newswire June 8, 2015

CEO Clarence Smith Reports on Edmonton Meetings with Dr. James Shapiro and his Team

Business Wire June 5, 2015

ProtoKinetix Announces Share Issuance

Business Wire May 6, 2015

ProtoKinetix Accepts Director's Resignation

Business Wire May 1, 2015

ProtoKinetix Announces Acquisition of Patents

Business Wire April 27, 2015

ProtoKinetix Announces Acquisition of Patents

Business Wire April 14, 2015

ProtoKinetix Announces Acquisition of Patents

Business Wire April 7, 2015

ProtoKinetix Announces Consulting Agreements

Business Wire April 3, 2015

ProtoKinetix Announces Share Issuance

Business Wire April 2, 2015

University of Alberta Diabetes Institute Encouraged by Preliminary Results of Testing of ProtoKinetix Licensed AAGP(TM) Molecule in Islet Cell Transplantation

Business Wire March 26, 2015

ProtoKinetix Announces Consulting Agreements

Business Wire March 17, 2015

ProtoKinetix Announces Settlement of Debt

Business Wire March 9, 2015

ProtoKinetix Announces Share Issuance and Closing of West Vancouver Office

Business Wire March 6, 2015

Dr. Julia Levy Accepts Position on ProtoKinetix' Business and Scientific Advisory Board

Business Wire February 26, 2015

ProtoKinetix Adds New Board Member

Business Wire February 26, 2015

ProtoKinetix Announces New President and Chief Executive Officer

Business Wire February 23, 2015

ProtoKinetix Announces Terms of Settlement Agreement with British Columbia Securities Commission

Business Wire February 23, 2015

ProtoKinetix Inc. Announces Termination of Intrepid Agreement

Business Wire October 28, 2014

ProtoKinetix Inc. Personnel Changes

Business Wire October 2, 2014

ProtoKinetix Welcomes Clarence E. Smith to its Board of Directors

Business Wire June 20, 2014